INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 311,880 | $1,309,896 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 91,683 | $385,069 | 0.01% |
| Point72 Asset Management, L.P. | 700,000 | $2,940,000 | 0.01% |
| Virtu Financial LLC | 10,518 | $44 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,326,871 | $5,572,858 | 0.00% |
| Parallel Advisors, LLC | 15,627 | $65,633 | 0.00% |
| Renaissance Technologies | 295,608 | $1,242 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 68,100 | $286,020 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 55,403 | $232,693 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,332 | $34,994 | 0.00% |
| SG Americas Securities, LLC | 14,452 | $61 | 0.00% |
| MARSHALL WACE, LLP | 135,783 | $570,289 | 0.00% |
| FMR LLC | 2,465,232 | $10,353,974 | 0.00% |
| MetLife Investment Management, LLC | 18,035 | $75,747 | 0.00% |
| TWO SIGMA ADVISERS, LP | 96,100 | $403,620 | 0.00% |
| Squarepoint Ops LLC | 42,607 | $178,949 | 0.00% |
| VANGUARD GROUP INC | 2,276,085 | $9,559,557 | 0.00% |
| RHUMBLINE ADVISERS | 45,929 | $192,897 | 0.00% |
| ROYAL BANK OF CANADA | 5,683 | $24,000 | 0.00% |
| BARCLAYS PLC | 9,220 | $39 | 0.00% |
External links
This page lists INOZYME PHARMA INC's shareholders in Q3 2023. To view INOZYME PHARMA INC's shareholder history, click here.